| Patents for A61P 23 - Anaesthetics (4,141) |
|---|
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/17/2004 | EP1397161A2 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 03/17/2004 | EP1242406B1 Novel compounds |
| 03/17/2004 | EP1202719A4 Anesthetic composition for intravenous injection comprising propofol |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | US20040048932 Anesthetic e.g., sevoflurane, enflurane, isoflurane, methoxyflurane, or desflurane, containing a Lewis acid inhibitor |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/04/2004 | US20040044084 Anesthetics; anticonvulsants; antiepileptic agents |
| 03/04/2004 | US20040044003 Therapeutic agents useful for treating pain |
| 03/03/2004 | EP1392670A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392381A1 An aerosol forming device for use in inhalation therapy |
| 03/03/2004 | EP1392263A2 Delivery of aerosols containing small particles through an inhalation route |
| 03/03/2004 | EP1392243A2 Topical composition with a lamellar double-membrane structure, containing a n-acyl-ethanolamine and/or a quaternary ammonium salt and/or an adenosylmethionine |
| 03/03/2004 | EP1392242A1 Method of forming an aerosol for inhalation delivery |
| 03/02/2004 | US6699908 Methods for providing safe local anesthesia |
| 03/02/2004 | US6698162 Methods of producing a terminally sterilized topical patch preparation |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696080 Vortexing lipid film with water; homogenizing suspension; repeatedly freeze-thawing in liquid nitrogen; encapsulation; giant multivesicular liposomes |
| 02/19/2004 | WO2004014841A1 Compounds, pro-drugs and conjugates derived from mexiletine |
| 02/19/2004 | WO2003075850A9 Methods for alzheimer's disease treatment and cognitive enhancement |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | US20040034002 3Alpha-hydroxy-3beta-methoxymethyl-substituted steroids and the use thereof |
| 02/18/2004 | EP1187635B1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist |
| 02/17/2004 | CA2408585C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/11/2004 | EP1387829A1 Novel pyridinone and related heterocyclic derivatives |
| 02/11/2004 | EP0781127B1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 02/05/2004 | WO2004010950A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 02/05/2004 | WO2004010941A2 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 02/05/2004 | US20040024021 Heatless separation via precipitation of diastereomeric salts with tartaric acid; improved anesthetics |
| 02/05/2004 | CA2492210A1 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385518A1 Benzimidazolone compounds |
| 02/04/2004 | EP1385517A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 02/04/2004 | EP1385514A1 Spiroindene and spiroindane compounds |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385484A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 02/04/2004 | EP1257304B1 Foam-forming wound dressing |
| 02/03/2004 | US6686370 8-(4,4-bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazospiro(4.5) decan-4-one, for example; treating pain with reduced side effects of opioid analgesics; affinity for opioid receptor-like (orl1) receptor |
| 01/29/2004 | WO2004009064A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 01/29/2004 | WO2003057153A3 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 01/28/2004 | EP1383487A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 01/28/2004 | EP1383486A2 Compositions containing cgmp pde inhibitors and local anestetic agents for nasal application |
| 01/28/2004 | EP1383445A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 01/28/2004 | EP0957900B1 Compositions and methods for topical application of therapeutic agents |
| 01/28/2004 | CN1136229C Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases |
| 01/27/2004 | US6682716 Delivery of aerosols containing small particles through an inhalation route |
| 01/22/2004 | US20040014718 Clear aqueous anaesthetic composition |
| 01/22/2004 | US20040013747 An anaesthetic mixture comprising a drug, acids, a metal nitrite; a membrane is used to prevent direct contact of the skin while diffusing the active drug and nitric oxide vasodilator; topical application |
| 01/21/2004 | EP1381368A2 Compositions containing imidazotriazinone for nasal application |
| 01/21/2004 | CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication |
| 01/21/2004 | CN1135104C Local anesthetic for external use |
| 01/20/2004 | US6680318 Piperazinomethylbenzamides as delta-opioid receptor agonists |
| 01/14/2004 | EP1380573A2 Isoquinolines and preparation thereof |
| 01/14/2004 | EP1380296A1 Hsp inductor |
| 01/14/2004 | EP1379636A2 Human neprilysin protease |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/13/2004 | US6677492 Sevoflurane |
| 01/13/2004 | US6677320 Mixture with chelate compound; bone disorders |
| 01/08/2004 | WO2003075850A3 Methods for alzheimer's disease treatment and cognitive enhancement |
| 01/07/2004 | CN1133461C Application of tigroid spider toxic extract in preparnig analgesic |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | CA2261119C Compositions comprising lidocaine and emu oil and methods of use thereof |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/01/2004 | US20040002536 Composition of melatonin for induction of general anesthesia |
| 01/01/2004 | US20040002523 Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 12/31/2003 | WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles |
| 12/31/2003 | WO2004000296A1 (2s)-2amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms |
| 12/30/2003 | US6670329 Isolated hybrid polypeptide |
| 12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
| 12/25/2003 | US20030236273 Aryl substituted pyrimidines and the use thereof |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105779A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/24/2003 | WO2003076414A3 Aryl substituted pyrimidines and the use thereof |
| 12/24/2003 | WO2003033048A3 Drug delivery system for conscious sedation |
| 12/24/2003 | CA2487122A1 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/18/2003 | WO2002007678A3 Mu-conopeptides |
| 12/18/2003 | US20030233086 Drug delivery system for conscious sedation |
| 12/18/2003 | US20030232891 For therapy of pain |
| 12/18/2003 | US20030232090 Anhydrous antifungal gel comprising polyhydric alcohol(s), a gelling agent and an antifungal azole such as econazole; treating oral and vaginal fungal and bacterial infections |
| 12/17/2003 | CN1131033C Anaesthetic formulation |
| 12/11/2003 | US20030228355 Precipitation of lipid; fineness particle size |
| 12/10/2003 | EP1368299A2 Substituted c-cyclohexylmethylamine derivatives |
| 12/10/2003 | EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 12/10/2003 | CN1130171C Stretchable hood utensil containing stretchable adhesive matrix at least in moisture state |
| 12/04/2003 | WO2003015748A3 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 12/04/2003 | US20030225080 Treating a disorder responsive to the blockade of sodium channels |
| 12/03/2003 | CN1460019A Improved injectable dispersions of propofol |